Navigating Clinical Trials in the Philippines and Malaysia: Insights and Opportunities
Due to a combination of large, diverse populations, effective healthcare infrastructure, and evolving regulatory and…
Article Date
January 28, 2026
This article is featured on another website.
Go to article
April 9, 2026
Kainova Therapeutics Expands Phase I / II Trial of DT-7012, a Treg-depleting Anti-CCR8 Antibody, with First Patient Dosed in Europe
April 9, 2026
Kainova Therapeutics Expands Phase I / II Trial of DT-7012, a Treg-depleting Anti-CCR8 Antibody, with First Patient Dosed in Europe
April 23, 2026
CRM Trial Connect 2026 Kuala Lumpur: Where to Find HiRO and What’s New
HiRO Attending CRM Trial Connect 2026 in Kuala Lumpur HiRO will be attending CRM Trial…
April 23, 2026
CRM Trial Connect 2026 Kuala Lumpur: Where to Find HiRO and What’s New
HiRO Attending CRM Trial Connect 2026 in Kuala Lumpur HiRO will be attending CRM Trial…